
Keywords: MAPK; mitogen-activated protein kinase; Actn2; actinin alpha 2; AMPK; adenosine monophosphate-activated protein kinase; Atf3; activating transcription factor 3; ATP; Adenosine triphosphate; b2MG; Beta-2-microglobulin; Bcl11a; B-cell CLL/lymphoma 11A; Bcl2